Farmacosmo Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2.01	3.12	5.07	6.85	1.41	2.06
Cash & Short-Term Investments	2.01	3.12	5.07	6.85	1.41	2.06
Cash Growth	-56.89%	-38.37%	-26.06%	385.48%	-31.44%	118.40%
Accounts Receivable	2.68	3.7	4.95	5.26	4.81	4.26
Other Receivables	1.11	1.07	1.86	4.88	0.87	0.28
Receivables	3.79	4.77	6.82	10.14	5.68	4.54
Inventory	9.93	9.26	7.33	4.73	2.08	0.98
Prepaid Expenses	-	-	-	0.17	-	-
Other Current Assets	0.09	-0	-	-	-	-
Total Current Assets	16.59	17.95	19.96	21.89	9.17	7.58
Property, Plant & Equipment	0.27	0.29	0.49	0.48	0.3	0.19
Long-Term Investments	0.06	0.05	0.05	0.05	0.06	0.02
Goodwill	7.73	8.28	10.85	11.18	0	0
Other Intangible Assets	2.72	2.93	2.87	2.32	0.59	0.5
Long-Term Accounts Receivable	-	-	-	0.05	-	-
Long-Term Deferred Charges	0.93	1.19	1.95	2.78	0.51	0.31
Other Long-Term Assets	0.25	0.18	0.23	0.47	0.14	0.1
Total Assets	28.55	30.87	36.4	39.24	10.77	8.71
Accounts Payable	10.03	10.24	11.91	14.5	8.01	7.24
Accrued Expenses	0.41	0.34	0.2	0.16	0.03	0.04
Current Portion of Long-Term Debt	6	6.65	5.19	0.69	0.24	0.1
Current Income Taxes Payable	0.44	0.38	0.32	0.41	0.39	0.41
Other Current Liabilities	1.12	0.73	0.78	2.19	0.16	0.09
Total Current Liabilities	18	18.34	18.41	17.96	8.83	7.88
Long-Term Debt	1.87	0.68	1.5	1.18	0.38	-
Long-Term Unearned Revenue	0.19	0.24	0.38	0.53	0.18	0.11
Long-Term Deferred Tax Liabilities	0	0.01	0.03	0.03	-	-
Other Long-Term Liabilities	0.76	0.77	0.7	0.54	0.42	0.17
Total Liabilities	20.82	20.03	21.03	20.22	9.8	8.15
Common Stock	3.48	3.48	3.48	3.01	0.07	0.07
Additional Paid-In Capital	13.79	13.79	13.79	14.26	-	-
Retained Earnings	-9.83	-6.58	-4.25	0.38	0.9	0.49
Treasury Stock	-0.11	-0.11	-0.11	-0.25	-	-
Comprehensive Income & Other	-0	-0	-0	-	-	-
Total Common Equity	7.34	10.58	12.91	17.4	0.97	0.55
Minority Interest	0.39	0.25	2.46	1.62	-	-
Shareholders' Equity	7.73	10.84	15.37	19.02	0.97	0.55
Total Liabilities & Equity	28.55	30.87	36.4	39.24	10.77	8.71
Total Debt	7.87	7.33	6.69	1.87	0.62	0.1
Net Cash (Debt)	-5.86	-4.21	-1.63	4.98	0.79	1.95
Net Cash Growth	-	-	-	530.10%	-59.56%	108.47%
Net Cash Per Share	-0.15	-0.11	-0.04	-	0.03	-
Filing Date Shares Outstanding	38.81	38.81	38.81	-	30	-
Total Common Shares Outstanding	38.81	38.81	38.81	-	30	-
Working Capital	-1.41	-0.39	1.55	3.94	0.35	-0.3
Book Value Per Share	0.19	0.27	0.33	-	0.03	-
Tangible Book Value	-3.11	-0.62	-0.81	3.89	0.38	0.05
Tangible Book Value Per Share	-0.08	-0.02	-0.02	-	0.01	-
Land	0.14	0.14	0.14	-	0.14	0.07
Machinery	0.44	0.43	0.56	-	0.28	0.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.